Alpharadin: Additional Phase II data

Additional 18-month, follow-up data from the double-blind, European Phase II trial (BC1-02) in 64 patients showed that Alpharadin improved

Read the full 191 word article

How to gain access

Continue reading with a
two-week free trial.